| Name | Dr. Martens |
|---|---|
| Epic | DOCS |
| Isin | GB00BL6NGV24 |
| Index | UK250 UK350 |
| Industry | Personal Goods |
| Latest share price | 70.15p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £676.47 | Debt ratio | n/a |
| Shares in issue | 963.09 | Debt-to-equity ratio | n/a |
| P/E ratio | 12.5 | Assets / equity ratio | n/a |
| Total dividends per share | 0.85p | Price to book value | n/a |
| Dividend yield | 2.9 | ROCE | 20.91 |
| Dividend cover | 2.75 | EPS growth | -46 |
| Earning per share | 7 | 52-week high / low | 50.55p / 97.80p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Interim | 2025-03-06 | 2025-04-08 | 0.85p |
| Final | 2024-08-29 | 2024-10-01 | 0.99p |
| Interim | 2024-01-04 | 2024-02-02 | 1.56p |
| Final | 2023-06-08 | 2023-07-18 | 4.28p |
| Interim | 2023-01-05 | 2023-02-03 | 1.56p |
| Final | 2022-06-09 | 2022-07-19 | 4.28p |
| Interim | 2022-01-13 | 2022-02-04 | 1.22p |
| Company name | Dr. Martens |
|---|---|
| Address | 28 Jamestown Road, Camden, London, United Kingdom, NW1 7BY |
| Telephone | |
| Website | http://www.drmartensplc.com |
| Director | Position |
|---|---|
| Mr Kenny Wilson | CEO |
| Mr Giles Wilson | CFO |
| Mr Paul Mason | Chairman |
| Ms Tara Alhadef | Non-Executive Director |
| Ms Lynne Weedall | Senior Independent Non-Executive Director |
| Miss Robyn Perriss | Independent Non-Executive Director |
| Mr Ian Rogers | Independent Non-Executive Director |
| Mr Andrew Harrison | Independent Non-Executive Director |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 31/03/24 | 31/03/23 | 31/03/22 |
| Intangible asssets and goodwill | 270 | 265.6 | 262.1 |
| Investments and other non-current assets | 1 | 1 | n/a |
| Total non-current assets | 515.2 | 483.8 | 415.5 |
| Inventory / work in progress | 254.6 | 257.8 | 123 |
| Trade and other receivables | 68.8 | 93 | 85.6 |
| Cash and equivalents | 111.1 | 157.5 | 228 |
| Other current assets and asset held for resale | 2.7 | 0.5 | 7 |
| Total of all assets | 952.4 | 992.6 | 859.1 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 153.5 | 164.5 | 155 |
| Long term liabilities | 430.7 | 423.9 | 375.9 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 584.2 | 588.4 | 530.9 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 368.2 | 404.2 | 328.2 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 9.6 | 10 | 10 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 1747.6 | 1782.2 | 1711.3 |
| Share premium account | n/a | n/a | n/a |
| Total equity | 368.2 | 404.2 | 328.2 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 122.2 | 176.2 | 229.3 |
| Pre-tax profit | 93 | 159.4 | 214.3 |